Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: SEC Gensler continues to express concern over SPACs; Revelation Biosciences receives approval to conduct Phase 2b viral challenge study
SEC’s Gensler Talks Up Crypto and SPAC Regulations
Securities and Exchange Commission Chairman Gary Gensler shed light on an array of hot-button topics during an interview on Monday, expressing his belief that “people will be hurt” if cryptocurrency markets are allowed operate beyond the remit of regulators, and voicing concerns that SPACs leave public market investors vulnerable.
Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99
Revelation Biosciences Inc., a clinical-stage life sciences company that is focused on the development of immunologic based therapies for the prevention and treatment of disease, announced today it has received approval from the Federal Agency for Medicines and Health Products and the local Committee of Medical Ethics in Belgium to conduct a Phase 2b influenza viral challenge study.
The Phase 2b, randomized, double-blind, influenza viral challenge study is planned in healthy volunteers. This viral challenge investigation will evaluate the potential efficacy of a single- and repeat-dose of REVTx-99 prophylaxis versus placebo on viral load and clinical illness influenza symptoms.
On August 30th, Revelation Biosciences entered into a definitive agreement to combine with Petra Acquisition, Inc. (NASDAQ:PAIC).
READ
Latest SPAC Liquidations: JAWS Hurricane JAWS Hurricane Acquisition Corporation (HCNE) to Liquidate on June 16 JAWS Hurricane Acquisition Corporation (Nasdaq: HCNE) today announced that its board of directors has determined not to proceed with a proposal to extend its corporate existence. As such, the Board has determined to cancel the special meeting of its stockholders,...
Jupiter Wellness Acquisition Corp. (NASDAQ:JWAC) announced this afternoon that it has completed its combination with Chinese carmaker Chijet. The deal was already approved by shareholders at a special meeting held on May 2, but at that time, the SPAC did not provide a timeline for the closing of the transaction. Although redemption numbers have still not...
The advent of summer is bringing nine lock-up expirations for de-SPAC’d companies and 10 on the sponsor side. The first change is to come for the sponsor of European Biotech Acquisition Corp., which closed its combination with Swiss pharma firm Oculis SA (NASDAQ:OCS) just three months ago. The sponsor is getting flexibility at a good...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Lucid to raise $3B in a common stock offering from Saudi owners, Betsy Cohen says SPACs will make a comeback, and SatixFy makes another leadership change Lucid Raising $3 Billion With More Money From...
An article on Bloomberg yesterday announced what many in SPAC Land have been wondering after UBS acquired Credit Suisse – where was Niron Stabinsky, the Head of SPACs at Credit Suisse, going to land? The answer is Banco Santander SA, in what appears to be a massive lift of most (or nearly all) of Credit...